The safety and efficacy of newly approved oral MS therapies. The differences between the induction and escalation approaches to MS treatment.

Chronic MS symptoms and their effects on quality of life.

The risk factors for postpartum MS relapses. Pregnancy planning and management strategies to moderate the risk of MS relapses.

The challenges in developing new MS therapies. The practical applications of individualizing MS therapy.

The communications issues that influence patients’ disease-modifying therapy decision-making. Potential strategies for addressing comorbidities in the clinical care of individuals with MS.

The role of emerging biomarkers, including optical coherence tomography and serum neurofilament light chain, in predicting future disability in MS.

Personalizing DMT regimens and the risk of medication non-adherence.

New Insights into Lifestyle Modification

Personalizing DMT Regimens/The Risks of Medication Non-Adherence

Incorporating MRI Results in Treatment Decision Making